MENU

HALO

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Halozyme Therapeutics (HALO) Ownership - Who owns Halozyme Therapeutics?

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies... Show more

Industry: #Biotechnology

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

12390 El Camino Real

Phone

+1 858 794-8889

Employees

423

Web

https://www.halozyme.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

8.18B

P/E Ratio

24.20

Total Cash

318.62M

Projected Growth

N/A

Total Debt

2.14B

Revenue

1.51B

Risk (Beta)

0.87

Dividend Yield

N/A

Total Cash/Share

2.69

Total Debt/Equity

74.60

Revenue/Share

12.27 USD as % of share price

View a ticker or compare two or three

VS

VS

Swing Trader for Mid Caps: Comprehensive Intrinsic Sentinel, 60 min, (FA)Swing Trader for Mid Caps: Comprehensive Intrinsic Sentinel, 60 min, (FA)

Annualized Return+21%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

HALO

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for HALO

A.I. Advisor

published General Information

General Information

a developer of recombinant human enzymes for the infertility, ophthalmology and oncology markets

Industry Biotechnology

Profile

Details

Industry

Biotechnology

Address

12390 El Camino Real

Phone

+1 858 794-8889

Employees

423

Web

https://www.halozyme.com